Last updated 2026-07-20
- Raised $900k grant led by Youdim Pharmaceuticals, Mar 2023
- Raised $1.9M Seed round led by Angels, 2017
Total raised
$2.8M
Last: Grant 2020-01
Stage
Seed
Founded
2017
Headcount
8
HQ
Acre, Israel
Sector
Health Tech & Life Sciences
Website ↗Registrar ID: 515605590 (Fibioseq Medical Ltd.)
About
Fibioseq Medical Ltd. develops orthopedic extremity implants designed to alleviate pain, restore natural motion, and promote independence in individuals suffering from chronic and debilitating wrist conditions due to disease, injury, and aging. The company's first product is the WristArt Implant, a total wrist arthroplasty implant designed with improved biomechanics and minimal bone invasion to provide near-normal range of motion and reduce common failure modes of existing solutions. Fibioseq Medical holds registered patents in the United States, Europe, China, and Israel.
Funding history · 2 rounds · $2.8M total
2 events/rounds · $2.8M Total Funding: $1.9M in Private Equity
Mar 2023
Grant
$900K
unknown
Headcount over time
8 employees (2026-09) · 1 point
Offices
Acre, Israel · HQ / main office
Q&A
- What is Fibioseq Medical's primary focus?
- Fibioseq Medical is a development-stage company focused on wrist joint replacement solutions, aiming to improve patient care in total wrist implants.
- Where is Fibioseq Medical headquartered?
- Fibioseq Medical is headquartered in Rosh HaNikra, North District, Israel.
- When was Fibioseq Medical founded?
- Fibioseq Medical was founded in February 2017.
- What is the key innovation of Fibioseq Medical's WristArt implant?
- The patented WristArt Total Wrist Arthroplasty implant features a double center of rotation, which enables near-normal range of motion while preserving critical blood flow to areas surrounding the prosthesis, and simplifies the procedure for surgeons.
- What is Fibioseq Medical's current employee count?
- Fibioseq Medical has 1-10 employees.
- What is the total amount raised by Fibioseq Medical to date?
- Fibioseq Medical has raised a total of $1,730,000 USD.
- When did Fibioseq Medical receive its most recent funding?
- Fibioseq Medical received its most recent funding in January 2020, a grant of $380,000 from the Israel Innovation Authority.
- Who are the co-founders of Fibioseq Medical?
- The co-founders of Fibioseq Medical are Harel Manor, who serves as Co-founder & CEO, and Lauren Gorelick, who is Co-founder & Head of Medical Division.
Team · 6
Harel Manor
Founder · CEO & Founder
Ofer Vikinsky
CTO
Dr. Lauren Gorelick
Clinical Director
Tamar Feurst
Regulatory Affairs & QA
Dr. Jeffrey Yao
Associate Prof. of Orthopedic Surgery-Hand & Upper Extremity Surgery
Prof. Natane LEVI
Professor and Doctor Honoris Causa
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatientsProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
surgeryorthopedicsmedical-productsmedical-devicessurgeonspatientsminimally-invasivebonetreatmentsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fibioseq.com |
|---|
Identifiers & details
| Legal name | Fibioseq Medical Ltd. |
|---|---|
| Founded | 2017-2 |
| Employees (exact) | 8 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | fibioseq.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515605590 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-02-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (1), annual_report (1) |
| Registered address | דרך המכללה 1 עכו |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-19 | הקצאת מניות |
| 2026-07-06 | דו~ח שנתי |